215 related articles for article (PubMed ID: 29016855)
21. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
[TBL] [Abstract][Full Text] [Related]
22. Targeting Hsc70-based autophagy to eliminate amyloid β oligomers.
Dou J; Su P; Xu C; Wen Z; Mao Z; Li W
Biochem Biophys Res Commun; 2020 Apr; 524(4):923-928. PubMed ID: 32057360
[TBL] [Abstract][Full Text] [Related]
23. Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment.
Chen Y; Wang B; Liu D; Li JJ; Xue Y; Sakata K; Zhu LQ; Heldt SA; Xu H; Liao FF
J Neurosci; 2014 Feb; 34(7):2464-70. PubMed ID: 24523537
[TBL] [Abstract][Full Text] [Related]
24. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
[TBL] [Abstract][Full Text] [Related]
25. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
26. Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau.
Abisambra J; Jinwal UK; Miyata Y; Rogers J; Blair L; Li X; Seguin SP; Wang L; Jin Y; Bacon J; Brady S; Cockman M; Guidi C; Zhang J; Koren J; Young ZT; Atkins CA; Zhang B; Lawson LY; Weeber EJ; Brodsky JL; Gestwicki JE; Dickey CA
Biol Psychiatry; 2013 Sep; 74(5):367-74. PubMed ID: 23607970
[TBL] [Abstract][Full Text] [Related]
27. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
[TBL] [Abstract][Full Text] [Related]
28. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
29. The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by Which LA1011 May Improve the Prognosis of Alzheimer's Disease.
Roe SM; Török Z; McGown A; Horváth I; Spencer J; Pázmány T; Vigh L; Prodromou C
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509087
[TBL] [Abstract][Full Text] [Related]
30. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.
Blair LJ; Nordhues BA; Hill SE; Scaglione KM; O'Leary JC; Fontaine SN; Breydo L; Zhang B; Li P; Wang L; Cotman C; Paulson HL; Muschol M; Uversky VN; Klengel T; Binder EB; Kayed R; Golde TE; Berchtold N; Dickey CA
J Clin Invest; 2013 Oct; 123(10):4158-69. PubMed ID: 23999428
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
33. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
34. Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain.
Lakshmana MK; Hayes CD; Bennett SP; Bianchi E; Reddy KM; Koo EH; Kang DE
FASEB J; 2012 May; 26(5):2072-83. PubMed ID: 22294787
[TBL] [Abstract][Full Text] [Related]
35. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
Zhang H; Chen W; Li Z; Huang Q; Wen J; Chang S; Pei H; Ma L; Li H
J Ethnopharmacol; 2024 Jan; 318(Pt B):116985. PubMed ID: 37532075
[TBL] [Abstract][Full Text] [Related]
36. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.
De Rossi P; Andrew RJ; Musial TF; Buggia-Prevot V; Xu G; Ponnusamy M; Ly H; Krause SV; Rice RC; de l'Estoile V; Valin T; Salem S; Despa F; Borchelt DR; Bindokas VP; Nicholson DA; Thinakaran G
Brain Pathol; 2019 Jul; 29(4):485-501. PubMed ID: 30506549
[TBL] [Abstract][Full Text] [Related]
37. The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics.
Fontaine SN; Martin MD; Akoury E; Assimon VA; Borysov S; Nordhues BA; Sabbagh JJ; Cockman M; Gestwicki JE; Zweckstetter M; Dickey CA
Hum Mol Genet; 2015 Jul; 24(14):3971-81. PubMed ID: 25882706
[TBL] [Abstract][Full Text] [Related]
38. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
[TBL] [Abstract][Full Text] [Related]
39. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
40. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
